Multiple studies verified in humans and rodents, that obesity changes the mRNA or protein expression levels of hepatic CYP3A in the liver and intestine, which was a major oxidatively metabolizing enzyme of tacrolimus (43–45). The gene discussed is CYP3A4; the disease is obesity disorder.